Reported 0 shares, down 2,016,314 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 271000 |
| 2022-03-31 | 258000 |
| 2022-06-30 | 139000 |
| 2022-09-30 | 115000 |
| 2022-12-31 | 81000 |
| 2023-03-31 | 73993 |
| 2023-06-30 | 34354 |
| 2023-06-30 | 0 |
| 2023-09-30 | 35567 |
| 2023-12-31 | 47511 |
| 2024-03-31 | 52819 |
| 2024-06-30 | 68572 |
| 2024-09-30 | 79239 |
| 2024-12-31 | 66872 |
| 2025-03-31 | 54205 |
| 2025-06-30 | 17798 |
| 2025-09-30 | 556018 |
| 2025-12-31 | 719028 |
| 2026-03-31 | 327979 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -2,016,314 (-100.0%) | 0 | $0 | 2026-08-12 | |
| Q1 2026 | Added | 2,016,314 | +613,520 (43.7%) | < 0.01% | $327,979 | 2026-05-15 | |
| Q4 2025 | Added | 1,402,794 | +589,544 (72.5%) | < 0.01% | $719,028 | 2026-02-09 | |
| Q3 2025 | Added | 813,250 | +762,074 (1489.1%) | < 0.01% | $556,018 | 2025-11-12 | |
| Q2 2025 | Reduced | 51,176 | -5,877 (-10.3%) | < 0.01% | $17,798 | 2025-08-08 | |
| Q1 2025 | Reduced | 57,053 | -1,097 (-1.9%) | < 0.01% | $54,205 | 2025-05-13 | |
| Q4 2024 | Added | 58,150 | +3,876 (7.1%) | < 0.01% | $66,872 | 2025-02-12 | |
| Q3 2024 | Added | 54,274 | +7,626 (16.3%) | < 0.01% | $79,239 | 2024-11-12 | |
| Q2 2024 | Added | 46,648 | +17,385 (59.4%) | < 0.01% | $68,572 | 2024-08-09 | |
| Q1 2024 | Added | 29,263 | +2,720 (10.2%) | < 0.01% | $52,819 | 2024-05-13 | |
| Q4 2023 | Unchanged | 26,543 | 0 (0.0%) | < 0.01% | $47,511 | 2024-02-13 | |
| Q3 2023 | Added | 26,543 | +9,536 (56.1%) | < 0.01% | $35,567 | 2023-11-13 | |
| Q2 2023 | Reduced | 0 | -255,148 (-100.0%) | 0 | $0 | 2023-08-11 | |
| Q2 2023 | New | 17,007 | +17,007 (0.0%) | < 0.01% | $34,354 | 2023-08-11 | |
| Q1 2023 | Reduced | 255,148 | -2,904 (-1.1%) | < 0.01% | $73,993 | 2023-05-15 | |
| Q4 2022 | Reduced | 258,052 | -385 (-0.1%) | < 0.01% | $81,000 | 2023-02-13 | |
| Q3 2022 | Unchanged | 258,437 | 0 (0.0%) | < 0.01% | $115,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 258,437 | 0 (0.0%) | < 0.01% | $139,000 | 2022-08-12 | |
| Q1 2022 | Unchanged | 258,437 | 0 (0.0%) | < 0.01% | $258,000 | 2022-05-13 | |
| Q4 2021 | Unchanged | 258,437 | 0 (0.0%) | < 0.01% | $271,000 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
24 managers reported PLUS THERAPEUTICS INC for Q2 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | Reduced | 0 | -271,599 | 0 | $0 | 2 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 0 | -2,427,098 | 0 | $0 | 2 qtrs |
| XTX Topco Ltd | Reduced | 0 | -116,023 | 0 | $0 | 3 qtrs |
| DAGCO Inc | Reduced | 0 | -25,882 | 0 | $0 | 4 qtrs |
| UBS Group AG | Reduced | 0 | -87,850 | 0 | $0 | 6 qtrs |
| Citigroup Inc | Reduced | 0 | -93,002 | 0 | $0 | 3 qtrs |
| GEODE CAPITAL MANAGEMENT LLC This report | Reduced | 0 | -2,016,314 | 0 | $0 | 13 qtrs |
| Miller Financial Services LLC | Reduced | 0 | -50,000 | 0 | $0 | 2 qtrs |
| ADVISOR GROUP HOLDINGS INC | Reduced | 0 | -133 | 0 | $0 | 13 qtrs |
| DANSKE BANK A S | Reduced | 0 | -1 | 0 | $0 | 2 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2026
- Filed
- August 12, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.